Heart Failure Society of America

From WikiMD's WELLNESSPEDIA

Heart Failure Society of America
[[File:|250px|alt=]]
Formation 1995
Type
Headquarters
Membership
Language
Leader title President
Leader name Randall C. Starling (2018)
Website


The Heart Failure Society of America is an American organization of heart failure experts who have an interest in heart function and heart failure. Founded in 1995,[1] it provides a forum for experts and patients with the aim of reducing the burden of heart failure.[2] It has produced advice on categorizing heart failure[3] and it produces guidelines including the 2010 comprehensive heart failure practice guidelines[4] and the 2013 Guideline for the Management of Heart Failure.[5] In 2018, a forum was created with people of various stages of advanced heart failure and specialists in cardiology.[6] Past presidents have included Mandeep R. Mehra, who took up the position in 2016.[7]

References[edit]

  1. ↑ HFSA Website(link).
  2. ↑ PAN Foundation - Heart Failure Society of America(link). panfoundation.org.Accessed 12 November 2018.
  3. ↑ Alexandre, Acute Heart Failure. online version, Springer Science & Business Media, ISBN 9781846287817, Pages: 5,
  4. ↑ Kelley M., The Advanced Practice Nurse Cardiovascular Clinician. online version, Springer Publishing Company, ISBN 9780826138576, Pages: 681,
  5. ↑ Wilcox, Jane."Stopping medication for heart failure with improved ejection fraction".The Lancet.2018;0(10166)
    8–10.doi:10.1016/S0140-6736(18)32825-3.PMID:30429051.Full text.
  6. ↑ Styles, Steve.Medscape Log In(link). www.medscape.com.6 November 2018.Accessed 12 November 2018.(subscription required)
  7. ↑ Administrator.Dr Mandeep Mehra(link). www.mgims.ac.in.Accessed 12 November 2018.
Stub icon

This article about a scientific organization is a stub. You can help WikiMD by expanding the page.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Heart_Failure_Society_of_America&oldid=5193382"